The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mycology Immunoassays Testing-Global Market Insights and Sales Trends 2025
Synopsis
Mycology immunoassays testing is a diagnostic method used to detect fungal infections by measuring specific immune responses to fungal antigens in patient samples.
The global Mycology Immunoassays Testing market size is expected to reach US$ 2605.3 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Mycology Immunoassays Testing in various end use industries. The expanding demands from the Hospitals, Blood Banks and Others,, are propelling Mycology Immunoassays Testing market. ELISA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rapid Tests segment is estimated at % CAGR for the next seven-year period.
The market for mycology immunoassays testing is driven by the need for accurate and timely diagnosis of fungal infections, which can have serious consequences if left untreated. The market's growth is also influenced by the increasing prevalence of fungal infections, particularly in immunocompromised individuals, and advancements in immunoassay technology, leading to improved sensitivity and specificity of fungal diagnostic tests.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mycology Immunoassays Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mycology Immunoassays Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mycology Immunoassays Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mycology Immunoassays Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mycology Immunoassays Testing covered in this report include Roche, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics, bioMérieux, ELITechGroup, MiraVista Diagnostics and Autobio Diagnostics CO.,Ltd., etc.
The global Mycology Immunoassays Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
bioMérieux
ELITechGroup
MiraVista Diagnostics
Autobio Diagnostics CO.,Ltd.
CapitalBio Corporation
Global Mycology Immunoassays Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mycology Immunoassays Testing market, Segment by Type:
ELISA
Rapid Tests
ELISPOT
Polymerase Chain Reaction (PCR)
Global Mycology Immunoassays Testing market, by Application
Hospitals
Blood Banks
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mycology Immunoassays Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Mycology immunoassays testing is a diagnostic method used to detect fungal infections by measuring specific immune responses to fungal antigens in patient samples.
The global Mycology Immunoassays Testing market size is expected to reach US$ 2605.3 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Mycology Immunoassays Testing in various end use industries. The expanding demands from the Hospitals, Blood Banks and Others,, are propelling Mycology Immunoassays Testing market. ELISA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rapid Tests segment is estimated at % CAGR for the next seven-year period.
The market for mycology immunoassays testing is driven by the need for accurate and timely diagnosis of fungal infections, which can have serious consequences if left untreated. The market's growth is also influenced by the increasing prevalence of fungal infections, particularly in immunocompromised individuals, and advancements in immunoassay technology, leading to improved sensitivity and specificity of fungal diagnostic tests.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mycology Immunoassays Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mycology Immunoassays Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mycology Immunoassays Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mycology Immunoassays Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mycology Immunoassays Testing covered in this report include Roche, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics, bioMérieux, ELITechGroup, MiraVista Diagnostics and Autobio Diagnostics CO.,Ltd., etc.
The global Mycology Immunoassays Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
bioMérieux
ELITechGroup
MiraVista Diagnostics
Autobio Diagnostics CO.,Ltd.
CapitalBio Corporation
Global Mycology Immunoassays Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mycology Immunoassays Testing market, Segment by Type:
ELISA
Rapid Tests
ELISPOT
Polymerase Chain Reaction (PCR)
Global Mycology Immunoassays Testing market, by Application
Hospitals
Blood Banks
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mycology Immunoassays Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Mycology Immunoassays Testing
1.1 Mycology Immunoassays Testing Market Overview
1.1.1 Mycology Immunoassays Testing Product Scope
1.1.2 Mycology Immunoassays Testing Market Status and Outlook
1.2 Global Mycology Immunoassays Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Mycology Immunoassays Testing Market Size by Region (2018-2029)
1.4 Global Mycology Immunoassays Testing Historic Market Size by Region (2018-2023)
1.5 Global Mycology Immunoassays Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Mycology Immunoassays Testing Market Size (2018-2029)
1.6.1 North America Mycology Immunoassays Testing Market Size (2018-2029)
1.6.2 Europe Mycology Immunoassays Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Mycology Immunoassays Testing Market Size (2018-2029)
1.6.4 Latin America Mycology Immunoassays Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Mycology Immunoassays Testing Market Size (2018-2029)
2 Mycology Immunoassays Testing Market by Type
2.1 Introduction
2.1.1 ELISA
2.1.2 Rapid Tests
2.1.3 ELISPOT
2.1.4 Polymerase Chain Reaction (PCR)
2.2 Global Mycology Immunoassays Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Mycology Immunoassays Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Mycology Immunoassays Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Mycology Immunoassays Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Mycology Immunoassays Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Mycology Immunoassays Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Mycology Immunoassays Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Mycology Immunoassays Testing Revenue Breakdown by Type (2018-2029)
3 Mycology Immunoassays Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Blood Banks
3.1.3 Others
3.2 Global Mycology Immunoassays Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Mycology Immunoassays Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Mycology Immunoassays Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Mycology Immunoassays Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Mycology Immunoassays Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Mycology Immunoassays Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Mycology Immunoassays Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Mycology Immunoassays Testing Revenue Breakdown by Application (2018-2029)
4 Mycology Immunoassays Testing Competition Analysis by Players
4.1 Global Mycology Immunoassays Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mycology Immunoassays Testing as of 2022)
4.3 Date of Key Players Enter into Mycology Immunoassays Testing Market
4.4 Global Top Players Mycology Immunoassays Testing Headquarters and Area Served
4.5 Key Players Mycology Immunoassays Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Mycology Immunoassays Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Mycology Immunoassays Testing Products, Services and Solutions
5.1.4 Roche Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Mycology Immunoassays Testing Products, Services and Solutions
5.2.4 Abbott Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Siemens
5.3.1 Siemens Profile
5.3.2 Siemens Main Business
5.3.3 Siemens Mycology Immunoassays Testing Products, Services and Solutions
5.3.4 Siemens Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Beckman Coulter Recent Developments
5.4 Beckman Coulter
5.4.1 Beckman Coulter Profile
5.4.2 Beckman Coulter Main Business
5.4.3 Beckman Coulter Mycology Immunoassays Testing Products, Services and Solutions
5.4.4 Beckman Coulter Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Beckman Coulter Recent Developments
5.5 Ortho-Clinical Diagnostics
5.5.1 Ortho-Clinical Diagnostics Profile
5.5.2 Ortho-Clinical Diagnostics Main Business
5.5.3 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Products, Services and Solutions
5.5.4 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Ortho-Clinical Diagnostics Recent Developments
5.6 bioMérieux
5.6.1 bioMérieux Profile
5.6.2 bioMérieux Main Business
5.6.3 bioMérieux Mycology Immunoassays Testing Products, Services and Solutions
5.6.4 bioMérieux Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.6.5 bioMérieux Recent Developments
5.7 ELITechGroup
5.7.1 ELITechGroup Profile
5.7.2 ELITechGroup Main Business
5.7.3 ELITechGroup Mycology Immunoassays Testing Products, Services and Solutions
5.7.4 ELITechGroup Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.7.5 ELITechGroup Recent Developments
5.8 MiraVista Diagnostics
5.8.1 MiraVista Diagnostics Profile
5.8.2 MiraVista Diagnostics Main Business
5.8.3 MiraVista Diagnostics Mycology Immunoassays Testing Products, Services and Solutions
5.8.4 MiraVista Diagnostics Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.8.5 MiraVista Diagnostics Recent Developments
5.9 Autobio Diagnostics CO.,Ltd.
5.9.1 Autobio Diagnostics CO.,Ltd. Profile
5.9.2 Autobio Diagnostics CO.,Ltd. Main Business
5.9.3 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Products, Services and Solutions
5.9.4 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Autobio Diagnostics CO.,Ltd. Recent Developments
5.10 CapitalBio Corporation
5.10.1 CapitalBio Corporation Profile
5.10.2 CapitalBio Corporation Main Business
5.10.3 CapitalBio Corporation Mycology Immunoassays Testing Products, Services and Solutions
5.10.4 CapitalBio Corporation Mycology Immunoassays Testing Revenue (US$ Million) & (2018-2023)
5.10.5 CapitalBio Corporation Recent Developments
6 North America
6.1 North America Mycology Immunoassays Testing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Mycology Immunoassays Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mycology Immunoassays Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mycology Immunoassays Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mycology Immunoassays Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mycology Immunoassays Testing Market Dynamics
11.1 Mycology Immunoassays Testing Industry Trends
11.2 Mycology Immunoassays Testing Market Drivers
11.3 Mycology Immunoassays Testing Market Challenges
11.4 Mycology Immunoassays Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
